Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 23, 2014 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma to Present at the Marcum MicroCap Conference

PORTLAND, Ore., May 23, 2014 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major...
May 21, 2014 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma to Present GALE-301 Phase 1 Data at the American Society of Clinical Oncology (ASCO) 50th Annual Meeting

PORTLAND, Ore., May 21, 2014 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major...
May 06, 2014 16:35 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Reports First Quarter 2014 Results

Abstral net revenue was $2.2 million in Q1 2014, with full year guidance of $11 to $15 million for 2014. Progress on clinical milestones for 2014 on track: completing enrollment in the Phase...
April 30, 2014 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma to Present at the 39th Annual Deutsche Bank Health Care Conference

PORTLAND, Ore., April 30, 2014 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address...
April 28, 2014 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Announces Department of Defense Grant for NeuVax(TM) (nelipepimut-S) Clinical Trial

Phase 2 study in neoadjuvant, HER2 3+ Breast Cancer Patients to commence in 2014 New study supports ongoing Phase 3 PRESENT study and Phase 2b in HER2 1+ and 2+ patients PORTLAND, Ore.,...
April 25, 2014 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma to Report First Quarter 2014 Financial Results on Tuesday, May 6, 2014

PORTLAND, Ore., April 25, 2014 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address...
April 24, 2014 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Research Pioneer Presented With 2014 Award for Excellence in Technology Transfer

PORTLAND, Ore., April 24, 2014 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address...
April 03, 2014 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma to Present at the 13th Annual Needham Healthcare Conference

PORTLAND, Ore., April 3, 2014 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major...
March 20, 2014 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Participates in Two Upcoming Conferences

PORTLAND, Ore., March 20, 2014 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address...
March 17, 2014 16:35 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Reports Fourth Quarter and Year End 2013 Results

Successful Abstral launch in Q4 2013 resulted in $2.5 million in net revenue consistent with guidance of $1.5 to $3 million. Galena is increasing its 2014 Abstral net revenue estimates to $11 to...